CoreWeave Securities Class Action Filed as Firms Urge Investors to Seek Lead Role by March 13
The complaint targets alleged misstatements about capacity, with single‑supplier risk highlighted by disclosures plus a Journal report on Core Scientific delays.
Overview
- The case, Masaitis v. CoreWeave, Inc., No. 2:26-cv-00355, is pending in the U.S. District Court for the District of New Jersey against the company and certain senior executives.
- Investors who bought CoreWeave securities from March 28, 2025 through December 15, 2025 face a March 13, 2026 deadline to seek appointment as lead plaintiff.
- Plaintiffs allege CoreWeave overstated its ability to meet AI demand and understated risks tied to reliance on a single third‑party data‑center provider linked to construction delays.
- Disclosures tied to the terminated Core Scientific merger on October 30, 2025, a November 10–11 guidance cut, and a December 15 Wall Street Journal report corresponded with share drops of over 6%, over 16%, and about 3%, respectively.
- Robbins Geller Rudman & Dowd, Bleichmar Fonti & Auld, and Kessler Topaz Meltzer & Check have issued notices inviting investors to discuss potential participation in the suit.